Condition: Focal Epilepsy · Sponsor: Biohaven Therapeutics Ltd.
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
This description comes directly from the study's public registry record.
Chief Medical Officer · 203-404-0410 · clinicaltrials@biohavenpharma.com
Always discuss trial participation with your own doctor first.
| Barrow Neurological Institute | Phoenix, Arizona, United States | Recruiting |
| Center for Neurosciences | Tucson, Arizona, United States | Recruiting |
| Clinical Trials, Inc. | Little Rock, Arkansas, United States | Recruiting |
| WRN | Rogers, Arkansas, United States | Withdrawn |
| University of California San Diego | La Jolla, California, United States | Recruiting |
| University of California, Los Angeles | Los Angeles, California, United States | Recruiting |
| Stanford Health Care | Palo Alto, California, United States | Recruiting |
| Profound Research LLC | Pasadena, California, United States | Recruiting |
| University of Colorado Anschultz Medical Campus | Aurora, Colorado, United States | Recruiting |
| Yale School of Medicine - Yale-New Haven Hospital | New Haven, Connecticut, United States | Recruiting |
| EZR Research LLC | Boca Raton, Florida, United States | Recruiting |
| Nova Clinical Research, LLC | Bradenton, Florida, United States | Recruiting |
+ 112 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06132893